businesspress24.com - Remedent Retains MZ Group as Its Investor Relations Advisor
 

Remedent Retains MZ Group as Its Investor Relations Advisor

ID: 1069749

(firmenpresse) - GHENT, BELGIUM -- (Marketwire) -- 01/04/12 -- Remedent, Inc. ("Remedent" or the "Company") (OTCBB: REMI), an international company specializing in research, development, and the manufacturing of oral care and cosmetic products, announced today that the Company has retained MZ Group as its investor relations advisor.

MZ Group will assist Remedent with communicating its corporate and financial developments to shareholders and investors, while implementing a strategy to enable management to build a sustainable public brand. Matthew Hayden, Scott Powell, and the MZ team will be advising the Company in all facets of corporate and financial communications.

"We selected MZ Group as our investor relations partner after careful review because of the breadth and depth of the advisory services they provide on a global level," said Mr. Guy De Vreese, Chairman and CEO of Remedent. "As we accelerate our core business strategies in 2012, we are confident that the team at MZ Group will provide strong support in conveying our business model, growth strategy, competitive advantages, and value proposition to shareholders and the investment community at large. With a rapidly evolving global story, Remedent will benefit from MZ Group's strong relationships with retail and institutional investors across several continents which will help us build our corporate brand and expand our shareholder base," concluded Mr. De Vreese.

"Remedent's breakthrough technology for dental veneers and its line of professional whitening and tooth sensitivity solutions are revolutionizing the cosmetic dental market," said Matthew Hayden, Chairman of MZ Group North America. "Both the Company's branded veneer franchise model across Europe and the Middle East and its GlamSmile branded operations in Asia are properly positioned to deliver meaningful growth over the coming years. Based on Remedent's prior successes with veneer and whitening technologies, Remedent plans to continue to develop other innovative dental technologies for the worldwide dental market in the near future. I believe that Remedent will benefit from MZ Group's ability to deliver capital markets awareness through a proven global platform, thus gaining exposure to a broader array of investors. We look forward to helping Mr. De Vreese and his team with all aspects of their corporate and investor communications needs," concluded Mr. Hayden.







MZ Group () is a wholly owned subsidiary of (at)titude Global () in North America. MZ Group is the world's largest independent global investor relations and corporate communications firm, providing innovative, customized services to domestic and multinational companies through a unique, fully integrated "one-stop-shop" business model. With offices in New York, Chicago, San Diego, São Paulo, Beijing, Shanghai, Hong Kong and Taipei, MZ Group has 300+ professionals serving more than 530 clients located throughout 10 countries.

Remedent, Inc. specializes in the research, development and manufacturing and the marketing of oral care and cosmetic dental products. The Company serves the professional dental industry with breakthrough technology for dental veneers. These products are supported by a line of professional veneer whitening and tooth sensitivity solutions. Headquartered in Belgium, Remedent distributes its products to more than 55 countries in the worldwide. For more information, go to .



Statements in this press release that are "forward-looking statements" are based on current expectations and assumptions that are subject to risks and uncertainties. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Remedent's actual operating results to be materially different from any historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as "believes," "belief," "expects," "expect," "intends," "intend," "anticipate," "anticipates," "plans," "plan," "projects," "project," to be uncertain and forward-looking. Actual results could differ materially because of factors such as Remedent's ability to achieve the synergies and value creation contemplated by the proposed transaction. For further information regarding risks and uncertainties associated with Remedent's business, please refer to the risk factors described in Remedent's filings with the Securities and Exchange Commission, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q. We undertake no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release.



For more information, please contact:



Remedent, Inc.
Stephen Ross
CFO
Phone: +1-310-922-5685
E-mail:

MZ Group
Scott Powell
Senior Vice President
Phone: +1-212-301-7130
E-mail:


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Ambucor Expanding Pacemaker and ICD Monitoring Programs
NexImmune Appoints Kenneth Carter, PhD, as President and CEO and Jonathan Schneck, MD, PhD as Chairman of Clinical and Scientific Advisory Board
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 04.01.2012 - 07:00 Uhr
Sprache: Deutsch
News-ID 1069749
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

GHENT, BELGIUM


Phone:

Kategorie:

Hospitals, Facilities and Providers


Anmerkungen:


Diese Pressemitteilung wurde bisher 87 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Remedent Retains MZ Group as Its Investor Relations Advisor
"
steht unter der journalistisch-redaktionellen Verantwortung von

Remedent, Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Remedent, Inc.



 

Who is online

All members: 10 565
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 94


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.